SuperworthThermo Fisher Scientific EPS TMO
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Sep 26, 2026
- $18.96
- Latest quarter, Q3 FY26
- $4.64
- +9% on a year earlier
- Fiscal year 2025
- $17.74
- +7% on the year before
Thermo Fisher Scientific's earnings per share was $18.96 over the twelve months to Sep 26, 2026, up 10% on a year earlier.
In its latest quarter, Q3 FY26, it was $4.64, up 9% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 2% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $17.74 | +7% |
| FY2024 | $16.53 | +7% |
| FY2023 | $15.45 | −12% |
| FY2022 | $17.65 | −9% |
| FY2021 | $19.46 | +22% |
| FY2020 | $15.97 | +74% |
| FY2019 | $9.16 | +26% |
| FY2018 | $7.25 | +29% |
| FY2017 | $5.60 | +10% |
| FY2016 | $5.09 | +4% |
| FY2015 | $4.91 | +4% |
| FY2014 | $4.71 | +36% |
| FY2013 | $3.47 | +8% |
| FY2012 | $3.21 | −7% |
| FY2011 | $3.46 | +36% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $4.64 | +9% | $18.96 | |
| Q2 FY26 | $4.68 | +9% | $18.59 | |
| Q1 FY26 | $4.43 | +11% | $18.19 | |
| Q4 FY25 | $5.21 | +9% | $17.74 | |
| Q3 FY25 | $4.27 | +0% | $17.31 | |
| Q2 FY25 | $4.28 | +6% | $17.29 | |
| Q1 FY25 | $3.98 | +15% | $17.05 | |
| Q4 FY24 | $4.78 | +14% | $16.53 | |
| Q3 FY24 | $4.25 | −4% | $15.95 | |
| Q2 FY24 | $4.04 | +15% | $16.12 | |
| Q1 FY24 | $3.46 | +4% | $15.59 | |
| Q4 FY23 | $4.20 | +4% | $15.45 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Thermo Fisher Scientific's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TMOThermo Fisher Scientific | $18.96 | +10% a year |
| DHRDanaher | $5.63 | +20% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| IQVIQVIA | $8.06 | +17% a year |
| WATWaters | $4.01 | −64% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| ILMNIllumina | $5.38 | −32% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| Peer median | $8.06 |
Where Thermo Fisher Scientific ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Thermo Fisher Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.